Upstream Processing

31. Thermo Fisher Scientific Single-Use Global Manufacturing Network 4/18/2022

    We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.

32. Next-Gen Medium And Feeds System To Improve CHO Cell Line Productivity 6/19/2024

    Choose the right CHO medium and feed system to optimize your upstream processes and secure a seamless scaling up.

33. Addressing Post-Translational Modifications In Novel Protein Therapeutics 9/13/2024

    Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.

34. Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities 11/2/2018

    Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.

35. Supporting Efficacy And Scaling With A Next-Generation T Cell AOF Formulation Medium 6/16/2025

    Explore a novel, next-generation medium designed with an animal component-free formulation to boost therapeutic potential and enable reproducible T cells.

36. Upstream To Downstream: A Comprehensive Approach To AAV Production 12/7/2023

    How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.

37. Enhancing Protein Quality Through Optimized Galactosylation 7/23/2025

    Advance your understanding of critical protein engineering. Explore expert strategies for optimizing complex molecular structures, paving the way for more effective and consistent biological products.

38. An Active Release Mechanism For Magnetic Separation And Cell Isolation 11/13/2023

    Discover an innovative active release solution that will serve autologous and allogeneic processes to the benefit of cell therapy patients.

39. Supply Chain Efficiency And Sourcing In Gene Therapy 11/4/2025

    An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.

40. mAb Up- And Downstream Process Intensification Strategies 12/12/2024

    Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.